Advertisement

Tumor Biology

, Volume 35, Issue 4, pp 3891–3897 | Cite as

Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk

  • Ming Shen
  • Yuan-Yuan Hu
  • Yu-Kun Hu
  • Long-Chuan Xie
  • Xiao-Ming Xu
  • Ming-Yue Wu
  • Yu-Ming Niu
Research Article

Abstract

The associations between CYP1B1 polymorphisms and head and neck squamous cell carcinoma (HNSCC) risk have been conflicting. We therefore performed a meta-analysis to derive a more precise relationship. Six published case–control studies were collected; odds ratios (ORs) with 95 % confidence interval (CI) were used to assess the association between CYP1B1 Leu432Val, Asn453Ser polymorphisms, and HNSCC risk. The Sensitivity analysis and publication bias also were performed to guarantee the statistical power. Overall, the pooled OR with 95 % CIs indicated that CYP1B1 Leu432Val polymorphism was significantly related with HNSCC risk (for Val vs. Leu: OR = 1.13, 95 % CI = 1.03–1.25, P = 0.014, P heterogeneity = 0.141; for Val/Val vs. Leu/Leu: OR = 1.30, 95 % CI = 1.06–1.60, P = 0.013, P heterogeneity = 0.253; for Val/Val vs. Leu/Leu + Leu/Val: OR = 1.23, 95 % CI = 1.05–1.46, P = 0.013, P heterogeneity = 0.456). The similar results were also been found in succeeding analysis of HWE and stratified analysis of Caucasian population. Furthermore, no significant association between CYP1B1 Asn453Ser polymorphism and HNSCC risk was found in this meta-analysis. In conclusion, our meta-analysis demonstrates that CYP1B1 Leu432Val polymorphism may be a risk factor for developing HNSCC.

Keywords

CYP1B1 Polymorphism Head and neck squamous cell carcinoma Meta-analysis 

Notes

Acknowledgment

This work was supported by the National Science Foundation of China (81170993) and the Natural Science Foundation of Taihe Hospital of Hubei University of Medicine (2011QD05). No competing financial interests exist.

Conflicts of interest

None

References

  1. 1.
    Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695–709.PubMedCrossRefGoogle Scholar
  2. 2.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.PubMedCrossRefGoogle Scholar
  3. 3.
    Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99–106.PubMedCrossRefGoogle Scholar
  4. 4.
    Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 2006;15:696–703.PubMedCrossRefGoogle Scholar
  5. 5.
    Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, et al. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem. 1996;271:28324–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis. 1999;20:1607–13.PubMedCrossRefGoogle Scholar
  7. 7.
    Perera FP. Environment and cancer: who are susceptible? Science. 1997;278:1068–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Ko Y, Abel J, Harth V, Brode P, Antony C, Donat S, et al. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res. 2001;61:4398–404.PubMedGoogle Scholar
  9. 9.
    Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45 Suppl 2:S3–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRefGoogle Scholar
  11. 11.
    Attia J, Thakkinstian A, D’Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297–303.PubMedCrossRefGoogle Scholar
  12. 12.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  13. 13.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Li G, Liu Z, Sturgis EM, Chamberlain RM, Spitz MR, Wei Q. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005;14:1034–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res. 2008;639:11–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, et al. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A. 2008;71:887–97.PubMedCrossRefGoogle Scholar
  17. 17.
    Tai J, Yang M, Ni X, Yu D, Fang J, Tan W, et al. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet. 2010;196:76–82.PubMedCrossRefGoogle Scholar
  18. 18.
    Soucek P, Susova S, Mohelnikova-Duchonova B, Gromadzinska J, Moraviec-Sztandera A, Vodicka P, et al. Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma. 2010;57:415–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos. 2001;29:1176–82.PubMedGoogle Scholar
  20. 20.
    Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Metabolism of benzo [a] pyrene and benzo [a] pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis. 1998;19:1847–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Wen X, Walle T. Preferential induction of CYP1B1 by benzo [a] pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis. 2005;26:1774–81.PubMedCrossRefGoogle Scholar
  22. 22.
    Murray GI, Melvin WT, Greenlee WF, Burke MD. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol. 2001;41:297–316.PubMedCrossRefGoogle Scholar
  23. 23.
    Port JL, Yamaguchi K, Du B, De Lorenzo M, Chang M, Heerdt PM, et al. Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis. 2004;25:2275–81.PubMedCrossRefGoogle Scholar
  24. 24.
    Spivack SD, Hurteau GJ, Jain R, Kumar SV, Aldous KM, Gierthy JF, et al. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res. 2004;64:6805–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Chi AC, Appleton K, Henriod JB, Krayer JW, Marlow NM, Bandyopadhyay D, et al. Differential induction of CYP1A1 and CYP1B1 by benzo [a] pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa. Oral Oncol. 2009;45:980–5.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Shatalova EG, Klein-Szanto AJP, Devarajan K, Cukierman E, Clapper ML. Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis. Cancer Prev Res (Phila). 2011;4:107–15.CrossRefGoogle Scholar
  27. 27.
    Pradhan S, Nagashri MN, Gopinath KS, Kumar A. Expression profiling of CYP1B1 in oral squamous cell carcinoma: counterintuitive downregulation in tumors. PLoS One. 2011;6:e27914.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Kolokythas A, Schwartz JL, Pytynia KB, Panda S, Yao M, Homann B, et al. Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. Oral Oncol. 2011;47:532–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Li DN, Seidel A, Pritchard MP, Wolf CR, Friedberg T. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics. 2000;10:343–53.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Ming Shen
    • 1
  • Yuan-Yuan Hu
    • 2
  • Yu-Kun Hu
    • 3
  • Long-Chuan Xie
    • 2
  • Xiao-Ming Xu
    • 2
  • Ming-Yue Wu
    • 4
  • Yu-Ming Niu
    • 1
    • 2
  1. 1.Institute of StomatologyNanjing Medical UniversityNanjingPeople’s Republic of China
  2. 2.Department of Stomatology and Evidence-Based Medicine Center, Taihe HospitalHubei University of MedicineShiyanPeople’s Republic of China
  3. 3.Department of Oral and Maxillofacial SurgeryThe First Affiliated Hospital of Anhui Medical UniversityHefeiPeople’s Republic of China
  4. 4.Stomatologic Hospital and CollegeAnhui Medical UniversityHefeiPeople’s Republic of China

Personalised recommendations